Certolizumab Inhibits Radiographic Progression Even in RA Patients with High Rheumatoid Factor Levels: A Pooled, Post-Hoc Analysis of Two Phase 3 Trials

被引：0
|
作者：
Smolen, Josef [1 ]
Burmester, Gerd [2 ]
Tanaka, Yoshiya [3 ]
Takeuchi, Tsutomu [4 ]
Curtis, Jeffrey [5 ]
Mikuls, Ted [6 ]
Lopez Medina, Clementina [7 ]
Taylor, Peter C. [8 ]
Tilt, Nicola [9 ]
Lauwerys, Bernard [10 ]
Ufuktepe, Baran [11 ]
Huizinga, Thomas [12 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany
[3] Univ Occupat & Environm Hlth, Dept Internal Med, Kitakyushu, Fukuoka, Japan
[4] Keio Univ, Dept Internal Med, Tokyo, Japan
[5] Univ Alabama Birmingham, Birmingham, AL USA
[6] Univ Nebraska Med Ctr, Omaha, NE USA
[7] Reina Sofia Univ Hosp, Cordoba, Spain
[8] Univ Oxford, Oxford, England
[9] UCB Pharma, Slough, England
[10] UCB Pharma, Brussels, Belgium
[11] UCB Pharma, Istanbul, Turkiye
[12] Leiden Univ, Dept Rheumatol, Leiden, Netherlands
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2286
引用
收藏
页码：4597 / 4600
页数：4
相关论文
共 50 条
  • [1] Tofacitinib Inhibits Radiographic Progression in Patients with Rheumatoid Arthritis Prone to Develop Structural Damage: A Post-Hoc Analysis of a Phase 3 Trial.
    van der Heijde, Desiree
    Landewe, Robert B. M.
    Gruben, David
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1075 - S1076
  • [2] Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trials
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    Haaland, Derek
    Hall, Stephen
    Inanc, Nevsun
    Li, Zhanguo
    Xavier, Ricardo M. M.
    Cara, Carlos
    Tilt, Nicola
    Taylor, Peter C. C.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (07) : 1248 - 1259
  • [3] Anamorelin in Cachectic Patients with Advanced NSCLC, a Post-Hoc Pooled Efficacy Data Analysis of Two Phase 3 Trials
    Currow, David
    Teme, Jennifer
    Abernethy, Amy
    Friend, John
    Fearons, Kenneth
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S665 - S666
  • [4] Sustainability of Linaclotide Response in Chronic Idiopathic Constipation Patients: A Post-hoc Pooled Analysis of Two Phase 3 Trials
    Lavins, Bernard J.
    Fox, Susan M.
    Reasner, David
    Tripp, Kenneth
    Shea, Elizabeth P.
    Blakesley, Rick
    Shiff, Steven
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S746 - S747
  • [5] CERTOLIZUMAB PEGOL IN PATIENTS WITH RHEUMATOID ARTHRITIS: POOLED EFFICACY ANALYSIS OF PHASE 3 CLINICAL TRIALS ACROSS BASELINE RHEUMATOID FACTOR QUARTILES
    Tanaka, Y.
    Li, Z.
    Inanc, N.
    Xavier, R.
    Tilt, N.
    Cara, C.
    Saadoun, C.
    Takeuchi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 267 - 268
  • [6] Antihistamine Use and Structural Progression of Knee OA: A Post-Hoc Analysis of Two Phase 3 Clinical Trials
    Bihlet, Asger
    Miller, Claire
    Byrjalsen, Inger
    Karsdal, Morten
    Andersen, Jeppe
    Rao, Tharaknath
    Baker, Matthew
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3742 - 3743
  • [7] RADIOGRAPHIC CHANGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ESTIMATED BASELINE YEARLY PROGRESSION ≥5 OR <5: POST HOC ANALYSIS OF TWO PHASE 3 TRIALS OF FILGOTINIB
    Tanaka, Y.
    Atsumi, T.
    Aletaha, D.
    Landewe, R. B. M.
    Bartok, B.
    Pechonkina, A.
    Yin, Z.
    Han, L.
    Emoto, K.
    Kano, S.
    Rajendran, V.
    Takeuchi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 604 - 605
  • [8] Radiographic Change in Patients with Rheumatoid Arthritis and Estimated Baseline Yearly Progression ≥5 or <5: Post Hoc Analysis of Two Phase 3 Trials of Filgotinib
    Tanaka, Yoshiya
    Atsumi, Tatsuya
    Aletaha, Daniel
    Landewe, Robert
    Bartok, Beatrix
    Pechonkina, Alena
    Han, Ling
    Emoto, Kahaku
    Kano, Shungo
    Rajendran, Vijay
    Takeuchi, Tsutomu
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 581 - 584
  • [9] Do High Rheumatoid Factor Levels Impact Response to Certolizumab Pegol in Patients with Inadequately Controlled Rheumatoid Arthritis? A Post Hoc Analysis of a Phase 3b Trial
    Smolen, Josef
    Mikuls, Ted
    Galloway, James
    Muller-Ladner, Ulf
    Curtis, Jeffrey
    Hashimoto, Motomu
    Takeuchi, Tsutomu
    Choy, Ernest
    Tanaka, Yoshiya
    Cara, Carlos
    Lauwerys, Bernard
    Tilt, Nicola
    Ufuktepe, Baran
    Taylor, Peter C.
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1036 - 1039
  • [10] Effects of Ertugliflozin on Liver Enzymes in Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis of Phase 3 Trials
    Gallo, Silvina
    Calle, Roberto A.
    Terra, Steven G.
    Pong, Annpey
    Tarasenko, Lisa
    Raji, Annaswamy
    DIABETES THERAPY, 2020, 11 (08) : 1849 - 1860
12345